At the news
? BULLISHIMPACT 7/10 8-K filed Jul 16, 2026 at 06:00 ET
UnitedHealth Group reported Q2 2026 GAAP EPS of $6.04 (vs consensus $4.87, +24.0% beat) and revenue of $112.0B (vs consensus $110.82B, +1.1% beat). The company raised full-year 2026 adjusted EPS guidance to $19.50-$20.00 from prior >$17.75, driven by strong medical cost management (MCR 86.7% vs 89.4% a year ago) and improved operating margins across both UnitedHealthcare and Optum. The beat-and-raise signals accelerating operational recovery from 2025 headwinds.
- Q2 2026 GAAP EPS $6.04 vs consensus $4.87 (beat by +24.0%)
- Q2 2026 revenue $112.0B vs consensus $110.82B (beat by +1.1%)
- Full-year 2026 adjusted EPS guidance raised to $19.50-$20.00 from >$17.75
- Medical cost ratio improved to 86.7% from 89.4% YoY, reflecting pricing discipline and cost management
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access